QL
RLAY icon

Quarry LP’s Relay Therapeutics RLAY Stock Holding History

Quarry LP’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35K Buy
+72
New +$1.04K ﹤0.01% 1846
2024
Q4 		– Sell
-36,000
Closed -$255K – 1949
2024
Q3 		$255K Buy
+36,000
New +$269K 0.06% 197

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Quarry LP's RLAY Position: Q2 2026 in Review

Quarry LP opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 72 shares worth $1.35K. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings. This is a return to the name: Quarry LP previously reported a position in RLAY as recently as Q3 2024.

Quarry LP first reported a position in RLAY in Q3 2024 and has held it in 2 quarters since. The position peaked at $255K in Q3 2024. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Quarry LP held 72 shares of Relay Therapeutics worth $1.35K as of Q2 2026.
  • Relay Therapeutics was a new Quarry LP position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1846 holding.
  • Quarry LP first reported a position in Relay Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • Quarry LP's Relay Therapeutics position peaked at $255K in Q3 2024.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.